Key facts
- Noze’s last known valuation is $9.9M (Dec 2017).
- It has raised $14.9M; the latest was Later Stage VC ($90K) in Apr 2025.
- Notable investors include Creative Destruction Lab, BDC Capital, Gates Foundation, Investissement Quebec, Desjardins Capital — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Noze
- ·The full record, as it builds
Funding rounds
No funding rounds for Noze are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Noze
Developer of digital odor perception technology designed to elevate human health and well-being. The company's technology replicates the human olfactory system, where a specialized sensor collects and sends data to a sophisticated AI engine for analysis that can sense the air quality and quantify chemicals footprints by their smell which are present in the environment, enabling healthcare providers to monitor and predict changes in health conditions, diagnose diseases, and conduct routine screenings with a single exhale.
- Sector
- Healthcare
- HQ
- Montreal, Canada
- Founded
- 2015
- Employees
- 49
- Website
- noze.ca/
- Ownership
- Privately Held (backing)
Noze doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Noze shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Noze in its N-PORT filings yet. We sweep new filings monthly.